The global market for Automated Peptide Synthesizer was valued at US$ 564 million in the year 2024 and is projected to reach a revised size of US$ 912 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Automated Peptide Synthesizer is an instrument used for peptide synthesis according to the principle of solid phase peptide synthesis.
The market for automated peptide synthesizers has experienced significant growth in recent years due to the rising demand for peptides in therapeutics, diagnostics, and research applications. Factors such as the increasing prevalence of chronic diseases, expanding drug discovery and development activities, and advancements in peptide-based therapeutics have positively impacted market growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Automated Peptide Synthesizer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Peptide Synthesizer.
The Automated Peptide Synthesizer market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Automated Peptide Synthesizer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automated Peptide Synthesizer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Gyros Protein Technologies AB
B眉chi AG
Biotage
CEM
CSBio
AAPPTec
Activotec
MultiSynTech
NJ Biopharmaceuticals LLC
Peptide Machines, Inc.
Protein Technologies, Inc.
Intavis AG
HAINAN JIANBANG PHARMACEUTICAL
Applied Biosystems Inc. (ABI)
Biotage
by Type
Single Channel
Multi-channel
by Application
School Laboratory
Biopharmaceutical Company
Synthesis Services Company
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Automated Peptide Synthesizer manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Automated Peptide Synthesizer by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Automated Peptide Synthesizer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Automated Peptide Synthesizer 麻豆原创 Overview
1.1 Product Definition
1.2 Automated Peptide Synthesizer by Type
1.2.1 Global Automated Peptide Synthesizer 麻豆原创 Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Single Channel
1.2.3 Multi-channel
1.3 Automated Peptide Synthesizer by Application
1.3.1 Global Automated Peptide Synthesizer 麻豆原创 Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 School Laboratory
1.3.3 Biopharmaceutical Company
1.3.4 Synthesis Services Company
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Automated Peptide Synthesizer Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Automated Peptide Synthesizer Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Automated Peptide Synthesizer Production Estimates and Forecasts (2020-2031)
1.4.4 Global Automated Peptide Synthesizer 麻豆原创 Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Automated Peptide Synthesizer Production 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Automated Peptide Synthesizer Production Value 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Key Players of Automated Peptide Synthesizer, Industry Ranking, 2023 VS 2024
2.4 Global Automated Peptide Synthesizer 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Automated Peptide Synthesizer Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Automated Peptide Synthesizer, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Automated Peptide Synthesizer, Product Offered and Application
2.8 Global Key Manufacturers of Automated Peptide Synthesizer, Date of Enter into This Industry
2.9 Automated Peptide Synthesizer 麻豆原创 Competitive Situation and Trends
2.9.1 Automated Peptide Synthesizer 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Automated Peptide Synthesizer Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Automated Peptide Synthesizer Production by Region
3.1 Global Automated Peptide Synthesizer Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Automated Peptide Synthesizer Production Value by Region (2020-2031)
3.2.1 Global Automated Peptide Synthesizer Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Automated Peptide Synthesizer by Region (2026-2031)
3.3 Global Automated Peptide Synthesizer Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Automated Peptide Synthesizer Production Volume by Region (2020-2031)
3.4.1 Global Automated Peptide Synthesizer Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Automated Peptide Synthesizer by Region (2026-2031)
3.5 Global Automated Peptide Synthesizer 麻豆原创 Price Analysis by Region (2020-2025)
3.6 Global Automated Peptide Synthesizer Production and Value, Year-over-Year Growth
3.6.1 North America Automated Peptide Synthesizer Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Automated Peptide Synthesizer Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Automated Peptide Synthesizer Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Automated Peptide Synthesizer Production Value Estimates and Forecasts (2020-2031)
4 Automated Peptide Synthesizer Consumption by Region
4.1 Global Automated Peptide Synthesizer Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Automated Peptide Synthesizer Consumption by Region (2020-2031)
4.2.1 Global Automated Peptide Synthesizer Consumption by Region (2020-2025)
4.2.2 Global Automated Peptide Synthesizer Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Automated Peptide Synthesizer Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Automated Peptide Synthesizer Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Automated Peptide Synthesizer Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Automated Peptide Synthesizer Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Netherlands
4.5 Asia Pacific
4.5.1 Asia Pacific Automated Peptide Synthesizer Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Automated Peptide Synthesizer Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Automated Peptide Synthesizer Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Automated Peptide Synthesizer Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Automated Peptide Synthesizer Production by Type (2020-2031)
5.1.1 Global Automated Peptide Synthesizer Production by Type (2020-2025)
5.1.2 Global Automated Peptide Synthesizer Production by Type (2026-2031)
5.1.3 Global Automated Peptide Synthesizer Production 麻豆原创 Share by Type (2020-2031)
5.2 Global Automated Peptide Synthesizer Production Value by Type (2020-2031)
5.2.1 Global Automated Peptide Synthesizer Production Value by Type (2020-2025)
5.2.2 Global Automated Peptide Synthesizer Production Value by Type (2026-2031)
5.2.3 Global Automated Peptide Synthesizer Production Value 麻豆原创 Share by Type (2020-2031)
5.3 Global Automated Peptide Synthesizer Price by Type (2020-2031)
6 Segment by Application
6.1 Global Automated Peptide Synthesizer Production by Application (2020-2031)
6.1.1 Global Automated Peptide Synthesizer Production by Application (2020-2025)
6.1.2 Global Automated Peptide Synthesizer Production by Application (2026-2031)
6.1.3 Global Automated Peptide Synthesizer Production 麻豆原创 Share by Application (2020-2031)
6.2 Global Automated Peptide Synthesizer Production Value by Application (2020-2031)
6.2.1 Global Automated Peptide Synthesizer Production Value by Application (2020-2025)
6.2.2 Global Automated Peptide Synthesizer Production Value by Application (2026-2031)
6.2.3 Global Automated Peptide Synthesizer Production Value 麻豆原创 Share by Application (2020-2031)
6.3 Global Automated Peptide Synthesizer Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Gyros Protein Technologies AB
7.1.1 Gyros Protein Technologies AB Automated Peptide Synthesizer Company Information
7.1.2 Gyros Protein Technologies AB Automated Peptide Synthesizer Product Portfolio
7.1.3 Gyros Protein Technologies AB Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Gyros Protein Technologies AB Main Business and 麻豆原创s Served
7.1.5 Gyros Protein Technologies AB Recent Developments/Updates
7.2 B眉chi AG
7.2.1 B眉chi AG Automated Peptide Synthesizer Company Information
7.2.2 B眉chi AG Automated Peptide Synthesizer Product Portfolio
7.2.3 B眉chi AG Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.2.4 B眉chi AG Main Business and 麻豆原创s Served
7.2.5 B眉chi AG Recent Developments/Updates
7.3 Biotage
7.3.1 Biotage Automated Peptide Synthesizer Company Information
7.3.2 Biotage Automated Peptide Synthesizer Product Portfolio
7.3.3 Biotage Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Biotage Main Business and 麻豆原创s Served
7.3.5 Biotage Recent Developments/Updates
7.4 CEM
7.4.1 CEM Automated Peptide Synthesizer Company Information
7.4.2 CEM Automated Peptide Synthesizer Product Portfolio
7.4.3 CEM Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.4.4 CEM Main Business and 麻豆原创s Served
7.4.5 CEM Recent Developments/Updates
7.5 CSBio
7.5.1 CSBio Automated Peptide Synthesizer Company Information
7.5.2 CSBio Automated Peptide Synthesizer Product Portfolio
7.5.3 CSBio Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.5.4 CSBio Main Business and 麻豆原创s Served
7.5.5 CSBio Recent Developments/Updates
7.6 AAPPTec
7.6.1 AAPPTec Automated Peptide Synthesizer Company Information
7.6.2 AAPPTec Automated Peptide Synthesizer Product Portfolio
7.6.3 AAPPTec Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.6.4 AAPPTec Main Business and 麻豆原创s Served
7.6.5 AAPPTec Recent Developments/Updates
7.7 Activotec
7.7.1 Activotec Automated Peptide Synthesizer Company Information
7.7.2 Activotec Automated Peptide Synthesizer Product Portfolio
7.7.3 Activotec Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Activotec Main Business and 麻豆原创s Served
7.7.5 Activotec Recent Developments/Updates
7.8 MultiSynTech
7.8.1 MultiSynTech Automated Peptide Synthesizer Company Information
7.8.2 MultiSynTech Automated Peptide Synthesizer Product Portfolio
7.8.3 MultiSynTech Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.8.4 MultiSynTech Main Business and 麻豆原创s Served
7.8.5 MultiSynTech Recent Developments/Updates
7.9 NJ Biopharmaceuticals LLC
7.9.1 NJ Biopharmaceuticals LLC Automated Peptide Synthesizer Company Information
7.9.2 NJ Biopharmaceuticals LLC Automated Peptide Synthesizer Product Portfolio
7.9.3 NJ Biopharmaceuticals LLC Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.9.4 NJ Biopharmaceuticals LLC Main Business and 麻豆原创s Served
7.9.5 NJ Biopharmaceuticals LLC Recent Developments/Updates
7.10 Peptide Machines, Inc.
7.10.1 Peptide Machines, Inc. Automated Peptide Synthesizer Company Information
7.10.2 Peptide Machines, Inc. Automated Peptide Synthesizer Product Portfolio
7.10.3 Peptide Machines, Inc. Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Peptide Machines, Inc. Main Business and 麻豆原创s Served
7.10.5 Peptide Machines, Inc. Recent Developments/Updates
7.11 Protein Technologies, Inc.
7.11.1 Protein Technologies, Inc. Automated Peptide Synthesizer Company Information
7.11.2 Protein Technologies, Inc. Automated Peptide Synthesizer Product Portfolio
7.11.3 Protein Technologies, Inc. Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Protein Technologies, Inc. Main Business and 麻豆原创s Served
7.11.5 Protein Technologies, Inc. Recent Developments/Updates
7.12 Intavis AG
7.12.1 Intavis AG Automated Peptide Synthesizer Company Information
7.12.2 Intavis AG Automated Peptide Synthesizer Product Portfolio
7.12.3 Intavis AG Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Intavis AG Main Business and 麻豆原创s Served
7.12.5 Intavis AG Recent Developments/Updates
7.13 HAINAN JIANBANG PHARMACEUTICAL
7.13.1 HAINAN JIANBANG PHARMACEUTICAL Automated Peptide Synthesizer Company Information
7.13.2 HAINAN JIANBANG PHARMACEUTICAL Automated Peptide Synthesizer Product Portfolio
7.13.3 HAINAN JIANBANG PHARMACEUTICAL Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.13.4 HAINAN JIANBANG PHARMACEUTICAL Main Business and 麻豆原创s Served
7.13.5 HAINAN JIANBANG PHARMACEUTICAL Recent Developments/Updates
7.14 Applied Biosystems Inc. (ABI)
7.14.1 Applied Biosystems Inc. (ABI) Automated Peptide Synthesizer Company Information
7.14.2 Applied Biosystems Inc. (ABI) Automated Peptide Synthesizer Product Portfolio
7.14.3 Applied Biosystems Inc. (ABI) Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Applied Biosystems Inc. (ABI) Main Business and 麻豆原创s Served
7.14.5 Applied Biosystems Inc. (ABI) Recent Developments/Updates
7.15 Biotage
7.15.1 Biotage Automated Peptide Synthesizer Company Information
7.15.2 Biotage Automated Peptide Synthesizer Product Portfolio
7.15.3 Biotage Automated Peptide Synthesizer Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Biotage Main Business and 麻豆原创s Served
7.15.5 Biotage Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Automated Peptide Synthesizer Industry Chain Analysis
8.2 Automated Peptide Synthesizer Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Automated Peptide Synthesizer Production Mode & Process Analysis
8.4 Automated Peptide Synthesizer Sales and 麻豆原创ing
8.4.1 Automated Peptide Synthesizer Sales Channels
8.4.2 Automated Peptide Synthesizer Distributors
8.5 Automated Peptide Synthesizer Customer Analysis
9 Automated Peptide Synthesizer 麻豆原创 Dynamics
9.1 Automated Peptide Synthesizer Industry Trends
9.2 Automated Peptide Synthesizer 麻豆原创 Drivers
9.3 Automated Peptide Synthesizer 麻豆原创 Challenges
9.4 Automated Peptide Synthesizer 麻豆原创 Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Gyros Protein Technologies AB
B眉chi AG
Biotage
CEM
CSBio
AAPPTec
Activotec
MultiSynTech
NJ Biopharmaceuticals LLC
Peptide Machines, Inc.
Protein Technologies, Inc.
Intavis AG
HAINAN JIANBANG PHARMACEUTICAL
Applied Biosystems Inc. (ABI)
Biotage
听
听
*If Applicable.